Koru Medical Systems, Inc. (KRMD) — SEC Filings
Koru Medical Systems, Inc. (KRMD) — 25 SEC filings. Latest: 8-K (Nov 25, 2025). Includes 10 8-K, 6 10-Q, 3 SC 13G/A.
View Koru Medical Systems, Inc. on SEC EDGAR
Overview
Koru Medical Systems, Inc. (KRMD) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Nov 25, 2025: KORU Medical Systems, Inc. entered into a Material Definitive Agreement on November 19, 2025. The filing also includes financial statements and exhibits related to this agreement. The company, formerly known as REPRO MED SYSTEMS INC, is incorporated in Delaware and headquartered in Mahwah, NJ.
Sentiment Summary
Across 25 filings, the sentiment breakdown is: 1 bearish, 22 neutral, 2 mixed. The dominant filing sentiment for Koru Medical Systems, Inc. is neutral.
Filing Type Overview
Koru Medical Systems, Inc. (KRMD) has filed 10 8-K, 6 10-Q, 2 10-K, 3 SC 13G/A, 2 SC 13G, 1 DEF 14A, 1 SC 13D/A with the SEC between Jan 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (25)
Risk Profile
Risk Assessment: Of KRMD's 19 recent filings, 1 were flagged as high-risk, 10 as medium-risk, and 8 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $10,402,163 |
| Net Income | -$777,966 |
| EPS | -$0.02 |
| Cash Position | $8,464,019 |
| Total Assets | $27,103,526 |
| Total Debt | $10,638,701 |
Key Executives
- United States
- Canada
- Michael J. O'Hanlon
- David L. Johnson
Industry Context
KORU Medical Systems operates in the medical device sector, specifically focusing on innovative solutions for vascular access. The industry is characterized by rapid technological advancements, stringent regulatory requirements, and a competitive landscape with both established players and emerging companies. Growth is often driven by the development of minimally invasive technologies and expanding access to healthcare globally.
Top Tags
10-Q (4) · financials (4) · filing (2) · Medical Devices (2) · 10-Q Filing (2) · shareholder-vote (2) · corporate-governance (2) · quarterly-report (2) · executive-compensation (2) · 10-K (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC File Number | 001-39086 | Identifies the company's filings with the SEC. |
| IRS Employer Identification No. | 13-3044880 | Company's tax identification number. |
| Net Revenues (Q3 2025) | $10,402,163 | Increased by 27.17% from $8,179,977 in Q3 2024 |
| Net Revenues (YTD Q3 2025) | $30,232,038 | Increased by 21.87% from $24,807,864 in YTD Q3 2024 |
| Net Loss (Q3 2025) | $777,966 | Improved from $1,580,817 net loss in Q3 2024 |
| Net Loss (YTD Q3 2025) | $2,151,070 | Improved from $4,505,490 net loss in YTD Q3 2024 |
| International Revenue (Q3 2025) | $3,695,524 | Increased by 219.14% from $1,157,166 in Q3 2024 |
| Cash and Cash Equivalents (Sept 30, 2025) | $8,464,019 | Decreased from $9,580,947 at Dec 31, 2024 |
| Research and Development (Q3 2025) | $933,107 | Decreased from $1,533,845 in Q3 2024 |
| Net Loss (Q2 2025) | $3.5M | Increased from $2.1M in Q2 2024, indicating worsening profitability. |
| Revenue (Q2 2025) | $12.8M | Decreased from $13.1M in Q2 2024, a 2.3% decline. |
| Net Loss (Six Months 2025) | $7.2M | Increased from $4.5M in the prior-year period, showing sustained losses. |
| Cash and Cash Equivalents (June 30, 2025) | $12.1M | Decreased from $15.3M at December 31, 2024, highlighting cash burn. |
| Total Assets (June 30, 2025) | $65.2M | Decreased from $68.5M at December 31, 2024, reflecting asset reduction. |
| Revenue Decline (Q2 2025 vs. Q2 2024) | 2.3% | Indicates a contraction in sales for the quarter. |
Forward-Looking Statements
- {"claim":"KORU Medical Systems, Inc. stock may experience short-term selling pressure due to the disclosed reduction in institutional ownership.","entity":"KORU Medical Systems, Inc.","targetDate":"Q1 2024","confidence":"medium"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Koru Medical Systems, Inc. (KRMD)?
Koru Medical Systems, Inc. has 25 recent SEC filings from Jan 2024 to Nov 2025, including 10 8-K, 6 10-Q, 3 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of KRMD filings?
Across 25 filings, the sentiment breakdown is: 1 bearish, 22 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Koru Medical Systems, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Koru Medical Systems, Inc. (KRMD) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Koru Medical Systems, Inc.?
Key financial highlights from Koru Medical Systems, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for KRMD?
The investment thesis for KRMD includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Koru Medical Systems, Inc.?
Key executives identified across Koru Medical Systems, Inc.'s filings include United States, Canada, Michael J. O'Hanlon, David L. Johnson.
What are the main risk factors for Koru Medical Systems, Inc. stock?
Of KRMD's 19 assessed filings, 1 were flagged high-risk, 10 medium-risk, and 8 low-risk.
What are recent predictions and forward guidance from Koru Medical Systems, Inc.?
Recent forward-looking statements from Koru Medical Systems, Inc. include guidance on {"claim":"KORU Medical Systems, Inc. stock may experience short-term selling pressure due to the disclosed reduction in .